T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 12/31/2016
Domestic Stock 59.7%
Domestic Bond 22.8%
Cash 9.4%
Foreign Stock 3.5%
Foreign Bonds 2.9%
Convertibles 1.4%
Preferreds 0.8%
Options -0.4%
Volatility and Other Measures
as of 12/31/2016
Beta 0.62
0.90
Standard Deviation 6.91
Price/Earnings Ratio (Domestic) 18.7
Earnings Growth Rate (Domestic) 11.2
Turnover Rate 61.6
Median Market
Capitalization
$53,842.09 Million
Sector Diversification
as of 12/31/2016
% of Total Net Assets
Health Care 15.5%
Information Technology 11.9%
Consumer Staples 11.0%
Financials 8.2%
Consumer Discretionary 8.0%
Industrials & Business Services 3.4%
Utilities 3.3%
Energy 1.4%
Real Estate 0.9%
Telecommunication Services 0.5%
Materials 0.4%
10 Largest Holdings
Represents 22.54 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Alphabet
Altria Group
Bank of New York Mellon
Danaher
Fiserv
Marsh & McLennan
Microsoft
PG&E
Philip Morris International
As of 12/31/2016 the Capital Appreciation Fund had a total of 298 holdings.
See Glossary for additional details on all data elements.